Effect of SAcubitril/Valsartan on left vEntricular ejection fraction and on the potential indication for Implantable Cardioverter Defibrillator in primary prevention: the SAVE-ICD study
Federico Guerra, Ernesto Ammendola, Matteo Ziacchi, Vittorio Aspromonte, Pier Luigi Pellegrino, Giuseppe Del Giorno, Gabriele Dell’Era, Lorenzo Pimpini, Francesco Santoro, Roberto Floris, Giulia Stronati, Gerardo Nigro, Pasquale Paolisso, Alessandro Guido, Giampiero Maglia, Natale Daniele Brunetti, Angelo Carbone, Miriam Gravellone, Roberto Antonicelli, Michele Cannone, Michele Accogli, Antonio Dello Russo, Pietro Palmisano
Topics & Concepts
Sacubitril, ValsartanSacubitrilValsartanMedicineEjection fractionCardiologyInternal medicineHeart failureCardiac resynchronization therapyImplantable cardioverter-defibrillatorSudden cardiac deathBlood pressureCardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors